tendance (1) toxicité (1) temps (durée) (1) sécurité (1) pharmacocinétique (1) modèle (1) gestion (1) exposition (1) effet (1) cancer (1) abords (agglomération) (1) survie (1) Treatment (1) Cancer (1) Inhibitors (1) Neutropenia (1) Time (1) Survival (1) Population (1) Pharmacokinetics (1) Patients (1) Neutrophils (1) Management (1) Fasting (1) Example (1) Day (1) Cancer (1) Breast (1) Absorption (1) Proportional hazards models (1)